Vanguard Group’s SeaStar Medical ICU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$90.6K Hold
37,738
﹤0.01% 4189
2025
Q3
$215K Buy
37,738
+31,988
+556% +$246K ﹤0.01% 4120
2025
Q2
$24.5K Hold
5,750
﹤0.01% 4239
2025
Q1
$95.4K Sell
5,750
-3,391
-37% -$63.8K ﹤0.01% 4145
2024
Q4
$177K Buy
9,141
+2,109
+30% +$60.2K ﹤0.01% 4118
2024
Q3
$300K Buy
7,032
+4,266
+154% +$286K ﹤0.01% 4077
2024
Q2
$210K Buy
2,766
+1,497
+118% +$160K ﹤0.01% 4162
2024
Q1
$233K Buy
1,269
+222
+21% +$43.5K ﹤0.01% 4152
2023
Q4
$116K Buy
+1,047
New +$155K ﹤0.01% 4284

Other funds holding ICU

Vanguard Group's ICU Position: Q4 2025 in Review

Vanguard Group held its SeaStar Medical (ICU) position steady in Q4 2025 at 37,738 shares worth $90.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4189.

Vanguard Group first reported a position in ICU in Q4 2023 and has held it in 9 quarters since. The position peaked at $300K in Q3 2024. 20 funds tracked by Wall St. Rank hold ICU as of Q4 2025.

  • Vanguard Group held 37,738 shares of SeaStar Medical worth $90.6K as of Q4 2025.
  • Vanguard Group left its SeaStar Medical share count unchanged in Q4 2025.
  • SeaStar Medical made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4189 holding.
  • Vanguard Group first reported a position in SeaStar Medical in Q4 2023 and has held it in 9 quarters since.
  • Vanguard Group's SeaStar Medical position peaked at $300K in Q3 2024.
  • 20 funds tracked by Wall St. Rank held SeaStar Medical as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.